Brainomix Partners with American Heart Association for Innovation
Brainomix Joins Innovators' Network to Drive Health Tech Innovation
American Heart Association consortium advances development of evidence-based health tech solutions
Brainomix, a global leader in AI-driven imaging tools focused on stroke management and lung disease, has announced its membership in the Innovators' Network of the American Heart Association's Center for Health Technology & Innovation. This collaboration seeks to enhance partnerships within the health technology sector, aiming to create scalable and impactful solutions.
The Innovators' Network serves as a consortium that unites entrepreneurs, healthcare providers, researchers, and payers. Together, they aim to propel innovation in cardiovascular and brain health. A significant advantage of being part of this network includes access to the Association's digital resources, which feature evidence-based scientific guidelines and clinical insights vital for the advancement of digital healthcare technologies.
Members of the Innovators' Network can actively collaborate with the Center in various capacities. One key aspect is the development of models for clinical outcome studies. By doing so, they can decrease the costs often associated with independent study developments. This integration of scientific prowess with technology ensures that digital platforms are proven to improve health outcomes—an important issue for healthcare providers and payers alike.
Robert A. Harrington, M.D., FAHA, a respected figure and former president of the American Heart Association, emphasized the Center's objectives: "The Center aims to fast-track the development of healthcare technology effectively and efficiently. Joining the Innovators' Network opens doors for members to leverage our consortium and broaden their participation in this critical field."
Excitement marks Brainomix's new role within the Innovators' Network. Michalis Papadakis, Ph.D., Co-Founder and CEO of Brainomix, shared, "We are proud to stand out as the sole AI-driven stroke company within this innovative consortium. Our collaboration with the American Heart Association will significantly enhance the integration of artificial intelligence in stroke assessments across various stages of patient care, ultimately empowering clinicians to make informed treatment decisions that significantly boost patient outcomes."
About Brainomix
Brainomix is recognized globally as a leader in AI-based medical imaging, dedicated to advancing precision medicine to bolster treatment choices in stroke and lung fibrosis. Their flagship product, Brainomix 360 Stroke, is the first fully automated AI imaging platform built for acute stroke assessments at various stages of the patient’s journey. This platform is designed to support healthcare professionals in making informed treatment and transfer decisions, ensuring that patients receive optimal care irrespective of local capabilities. Additionally, Brainomix 360 e-Lung technology employs advanced AI-driven CT biomarkers to monitor and predict disease progression in pulmonary fibrosis. Originating from a spin-off at the University of Oxford, Brainomix operates in more than 20 countries with offices in the UK, Ireland, and the USA.
For more information about Brainomix and its innovative technologies, visit www.brainomix.com and engage with the company on social media platforms such as Twitter, LinkedIn, and Facebook.
Contact Information
Jeff Wyrtzen, Chief Marketing Officer
T +44 (0)1865 582730
Media Inquiries in the USA
Jason Braco, Ph.D., LifeSci Communications
Media Inquiries for the UK & Europe
Sue Charles, Charles Consultants
Frequently Asked Questions
What is the purpose of the Innovators' Network?
The Innovators' Network aims to facilitate collaboration among entrepreneurs, researchers, and healthcare providers to promote innovation in cardiovascular and brain health.
Who is Brainomix?
Brainomix is a pioneering company specializing in AI-driven imaging tools that enhance decision-making in stroke and respiratory diseases.
What benefits do members gain from joining the Innovators' Network?
Members gain access to evidence-based guidelines, collaborative opportunities, and support for developing impactful health technologies.
Why is AI important in stroke assessment?
AI enhances the accuracy and efficiency of stroke assessments, enabling clinicians to make timely and informed treatment decisions, ultimately improving patient outcomes.
Where can I find more about Brainomix products?
For detailed information about Brainomix and its products, you can visit their official website at www.brainomix.com.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
